Search company, investor...

Atairgin Technologies

Founded Year



Recap | Dead

Total Raised


Last Raised


About Atairgin Technologies

Developer of platform technology based on bioactive lipids, or extracellular regulating agents. The company's technology enables multiple platform applications in cancer, pregnancy management, and reproductive health.

Headquarters Location

101 Theory First Floor

Irvine, California, 92612,

United States


Missing: Atairgin Technologies's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Atairgin Technologies's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Atairgin Technologies Frequently Asked Questions (FAQ)

  • When was Atairgin Technologies founded?

    Atairgin Technologies was founded in 1996.

  • Where is Atairgin Technologies's headquarters?

    Atairgin Technologies's headquarters is located at 101 Theory, Irvine.

  • What is Atairgin Technologies's latest funding round?

    Atairgin Technologies's latest funding round is Recap.

  • How much did Atairgin Technologies raise?

    Atairgin Technologies raised a total of $17.2M.

  • Who are the investors of Atairgin Technologies?

    Investors of Atairgin Technologies include Fremont Ventures, Frantz Medical Ventures and Oakwood Medical Investors.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.